Immunomodulatory receptor LAG3 and CTLA-4 may play lesser roles in DLBCL, as no differences in LAG3 expression on immune cells in the tumor microenvironment were observed compared to heathy donors [128]. Here, CTLA4 is linked to diffuse large B-cell lymphoma.